Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

KinDex Therapeutics describes novel agent for diabetes

July 12, 2012

FGF-21 analogue fusion protein developed for treating diabetes

July 12, 2012

Research in Taiwan reveals new potential target for ovarian cancer therapy

July 11, 2012

Inotuzumab ozogamicin shows promise in NHL and ALL

July 11, 2012

Ligand Pharmaceuticals divulges new results on LGD-6972

July 11, 2012

Rhizen Pharmaceuticals presents novel candidate steatohepatitis/diabetes drugs

July 11, 2012

Data reported from five clinical studies of panobinostat

July 11, 2012

Potential biomarker of AMD identified

July 10, 2012

First-in-human study of EP-100 complete

July 10, 2012

PARP-1/2 inhibitor shows promising safety profile in patients with cancer

July 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...